Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
0 hedge funds and large institutions have $0 invested in Guardion Health Sciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 15 closing their positions.
100% less funds holding
Funds holding: 15 → 0 (-15)
100% less capital invested
Capital invested by funds: $588K → $0 (-$588K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$215K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$95.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$82.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$69.9K |
| 5 |
HF
HRT Financial
New York
|
-$64K |
GHSI Hedge Fund Activity: Q4 2024 in Review
0 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2024, worth a combined $0 — down 100% from $588K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of GHSI and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, exiting entirely with an estimated $215K sold.
- 0 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2024, down from 15 in Q3 2024.
- Funds reported $0 of Guardion Health Sciences, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2024 and 15 closed out, a net change of -15 holders.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2024 was Renaissance Technologies, an estimated $215K sold.
Based on aggregated 13F filings for Q4 2024.